Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.
about
Emerging concepts in pancreatic cancer medicine: targeting the tumor stromaThalidomide in the treatment of cancer cachexia: a randomised placebo controlled trialHow Grim is Pancreatic Cancer?Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted NanovesiclesSystemic treatment for inoperable pancreatic adenocarcinoma: review and updateGatifloxacin induces S and G2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53Gemcitabine plus erlotinib for advanced pancreatic cancer: a systematic review with meta-analysisClinical Translation of Nanomedicine.A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.Meta-analysis of inoperable pancreatic cancer: gemcitabine combined with cisplatin versus gemcitabine alone.Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer.Meta-analysis on inoperable pancreatic cancer: a comparison between gemcitabine-based combination therapy and gemcitabine alone.A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumorsMeta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses.Gemcitabine versus gemcitabine combined with cisplatin treatment locally advanced or metastatic pancreatic cancer: a retrospective analysis.Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I(131) KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma.Triplet cytotoxic chemotherapy with gemcitabine, 5-fluorouracil and cisplatin for advanced pancreatic cancerGemcitabine plus cisplatin versus gemcitabine alone in the treatment of pancreatic cancer: a meta-analysisRecent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer.The role of radiotherapy in multimodal treatment of pancreatic carcinomaCurrent and emerging therapies for the treatment of pancreatic cancer.Pancreatic adenocarcinomaRandomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group StudyA Bayesian meta-analysis of multiple treatment comparisons of systemic regimens for advanced pancreatic cancer.Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pancreatic cancer.A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas.A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma.Efficacy of platinum chemotherapy agents in the adjuvant setting for adenosquamous carcinoma of the pancreas.Systemic therapy for metastatic pancreatic adenocarcinoma.ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer.Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies.Recent developments in the pharmacological treatment of advanced pancreatic cancer.Docetaxel as salvage therapy in highly pretreated and drug resistant gastrointestinal carcinomas.Advanced pancreatic cancer: is there a role for combination therapy?Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway.Oncolytic virotherapy for pancreatic cancer.Review article: chemotherapy for pancreatic cancer.
P2860
Q24627664-C6AD83C8-AF7E-4B5B-B6FD-9C65883A0EC1Q24685678-72616E26-9150-4353-AF7B-62E2E40367CEQ26740598-9B47BA79-76BF-4105-A33F-BD8070CD585CQ26828959-936AC59A-24AD-4FB8-A1D8-1FD146A91880Q26830913-97E86DE3-4EE0-4436-BE5E-17E43DC00D11Q28484635-78444D67-CA76-4FCC-B449-7D70FD3CA735Q28487656-F494116B-1A87-4698-AF39-7491460FBB29Q30355939-0C15A2B6-57C3-40D6-B567-E4D55800C424Q33265964-CA20CACC-CE8E-4150-8FCA-625C31A369C1Q33326148-808AE050-5642-47C4-9244-D2FEB7419ACBQ33369923-FD902F9C-E17F-4C5B-AB3E-3A5454C4B54AQ33371225-2E2A1938-F880-45E0-8158-3DF7A800E6FEQ33373308-673CE36F-F717-49B2-967E-62C4AE8C8D3FQ33377668-7F89240B-CCD9-40BB-B0CB-4B6DA781D861Q33380084-6EC542D9-6E90-4FC9-9708-D4EBC3BF7A50Q33385864-5EADB2A1-A7FA-46ED-9290-25B2DB5231C2Q33389637-7997548E-3A78-47C4-939A-8E4B7B424A56Q33403498-2F880946-BDB8-4791-A1B7-D2DACEAE061FQ33412585-2F09D899-411E-486F-87FA-D9A3385E8538Q33428016-6A46AC2A-2952-429B-A92E-3B6AA9E7D2A3Q33430378-2D49F4E3-03E8-4AA0-B795-A8E7077635C2Q33632330-1A3FE3E9-535C-4ABA-A148-778382C0E71FQ34025910-BAA7E31E-B52A-4CCD-9515-B363E4041F6BQ34129346-B8BF071D-8971-4B3A-A05C-0620193C336EQ34140498-8FB0903F-38F5-4400-9809-153BA302888BQ34257664-5AEE88FF-33EA-4412-94F6-9664904004BAQ34294011-9D3B298F-7E25-446C-AB43-470047392A77Q34346758-708B118B-CFD2-49AF-A427-976A54BE2C7FQ34750537-71C5E701-41B3-4B31-A954-E3DB1CFC1DBDQ34818494-D9075A1B-EA67-4096-9B02-5EA68EDCFA95Q35028999-BCCFC9A2-77C9-47D9-8B47-6C08CE27D6BCQ35076238-6A2AD9D2-C751-41E1-90E8-84766373351DQ35098294-B59F511F-85FE-4CF9-B7BF-28D09E504FB7Q35136815-8A287149-4AEF-45D5-989B-BB13707FD80BQ35144004-422A77E5-215E-4AD9-B57B-7DC2677A876BQ35181089-1744D384-DAC4-40A6-84F8-5E8EBD283ECCQ35576200-407F0FD0-1B5B-46BE-8AC7-1A06222E1B27Q35578720-D6077C51-11AD-41CA-89CE-AC6D4825795BQ35590996-FD0A374D-1B5E-4825-8753-677CDBFCC122Q35599597-EF338254-5E7C-4077-A828-264FAF2A7EB8
P2860
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Gemcitabine alone or with cisp ...... logia dell'Italia Meridionale.
@ast
Gemcitabine alone or with cisp ...... logia dell'Italia Meridionale.
@en
Gemcitabine alone or with cisp ...... logia dell'Italia Meridionale.
@nl
type
label
Gemcitabine alone or with cisp ...... logia dell'Italia Meridionale.
@ast
Gemcitabine alone or with cisp ...... logia dell'Italia Meridionale.
@en
Gemcitabine alone or with cisp ...... logia dell'Italia Meridionale.
@nl
prefLabel
Gemcitabine alone or with cisp ...... logia dell'Italia Meridionale.
@ast
Gemcitabine alone or with cisp ...... logia dell'Italia Meridionale.
@en
Gemcitabine alone or with cisp ...... logia dell'Italia Meridionale.
@nl
P2093
P356
P1433
P1476
Gemcitabine alone or with cisp ...... logia dell'Italia Meridionale.
@en
P2093
Antonio Testa
Evaristo Maiello
Francesco Giuliani
Generoso Uomo
Giuseppe Colucci
Maria Biglietto
Massimo Lopez
Piergiorgio Rabitti
Silvio Cigolari
Vittorio Gebbia
P304
P356
10.1002/CNCR.10323.ABS
P407
P577
2002-02-01T00:00:00Z